AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 10985715 — intervention group
Group type: EXPERIMENTAL
Intervention: Thrombolytic therapy (TT)
Number of subjects: 856
Study 10985715 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-aortic balloon pump (IABP)
Number of subjects: 856
Study 10985715 — intervention group
Group type: EXPERIMENTAL
Intervention: TT + IABP
Number of subjects: 856
Study 10985715 — intervention group
Group type: EXPERIMENTAL
Intervention: IABP only
Number of subjects: 856
Study 10985715 — intervention group
Group type: EXPERIMENTAL
Intervention: TT only
Number of subjects: 856
Study 10985715 — intervention group
Group type: COMPARATOR
Intervention: No TT, no IABP
Number of subjects: 856
Study 10985715 — intervention group
Group type: EXPERIMENTAL
Intervention: Revascularization
Number of subjects: 856
Study 10985715 — intervention group
Group type: EXPERIMENTAL
Intervention: Early IABP (< or = 6 h after TT)
Number of subjects: 856
Study 10985715 — intervention group
Group type: EXPERIMENTAL
Intervention: Late IABP
Number of subjects: 856
Study 9417486 — intervention group
Group type: EXPERIMENTAL
Intervention: Selenium substitution (Se+)
Number of subjects: 42
Study 9417486 — intervention group
Group type: COMPARATOR
Intervention: Control (Se-)
Number of subjects: 42
Study 8245998 — intervention group
Group type: EXPERIMENTAL
Intervention: CBC ConstaVac reinfusion system (57 patients: 35 TKAs and 22 THAs)
Number of subjects: 111
Study 8245998 — intervention group
Group type: COMPARATOR
Intervention: ConstaVac collection unit (54 patients: 34 TKAs and 20 THAs)
Number of subjects: 111
Study 2937625 — intervention group
Group type: EXPERIMENTAL
Intervention: Thrombolysis alone (group I, 64 patients)
Number of subjects: 127
Study 2937625 — intervention group
Group type: EXPERIMENTAL
Intervention: Thrombolysis and dilatation (group II, 63 patients)
Number of subjects: 127
Study 2937625 — intervention group
Group type: EXPERIMENTAL
Intervention: Successful dilatation
Number of subjects: 127
Study 2937625 — intervention group
Group type: EXPERIMENTAL
Intervention: Failed dilatation
Number of subjects: 127
Study 30617927 — intervention group
Group type: EXPERIMENTAL
Intervention: PGT-A group (n = 109)
Number of subjects: 220
Study 30617927 — intervention group
Group type: COMPARATOR
Intervention: Morphology group (n = 111)
Number of subjects: 220
Study 29528692 — intervention group
Group type: EXPERIMENTAL
Intervention: Nerve growth factor injections
Number of subjects: 16
Study 29528692 — intervention group
Group type: COMPARATOR
Intervention: Isotonic saline injections
Number of subjects: 16
Study 27230397 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-gloved conditions
Number of subjects: 1466
Study 27230397 — intervention group
Group type: COMPARATOR
Intervention: Double-gloved conditions
Number of subjects: 1466
Study 27230397 — intervention group
Group type: COMPARATOR
Intervention: Double-gloved conditions with finer 4.0 suture
Number of subjects: 1466
Study 25437217 — intervention group
Group type: EXPERIMENTAL
Intervention: Early nutritional support via the parenteral route
Number of subjects: 0
Study 25437217 — intervention group
Group type: COMPARATOR
Intervention: Early nutritional support via the enteral route
Number of subjects: 0
Study 22796236 — intervention group
Group type: EXPERIMENTAL
Intervention: Spontaneous triggering of ovulation (spontaneous LH group)
Number of subjects: 300
Study 22796236 — intervention group
Group type: COMPARATOR
Intervention: Administration of HCG (HCG group)
Number of subjects: 300
Study 20114095 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal manipulation (8 treatments)
Number of subjects: 80
Study 20114095 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal manipulation (16 treatments)
Number of subjects: 80
Study 20114095 — intervention group
Group type: EXPERIMENTAL
Intervention: Light massage (8 treatments)
Number of subjects: 80
Study 20114095 — intervention group
Group type: EXPERIMENTAL
Intervention: Light massage (16 treatments)
Number of subjects: 80
Study 20114095 — intervention group
Group type: EXPERIMENTAL
Intervention: Expectancy
Number of subjects: 80
Study 20114095 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-provider encounter (PPE)
Number of subjects: 80
Study 18844804 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-report measures tested for reliability and validity in populations of people with schizophrenia who use cannabis
Number of subjects: 0
Study 18844804 — intervention group
Group type: EXPERIMENTAL
Intervention: Biochemical tests for cannabis
Number of subjects: 0
Study 15678399 — intervention group
Group type: COMPARATOR
Intervention: No covering of the eye (group 1)
Number of subjects: 133
Study 15678399 — intervention group
Group type: EXPERIMENTAL
Intervention: Transparent eye shield for four hours (group 2)
Number of subjects: 133
Study 15678399 — intervention group
Group type: EXPERIMENTAL
Intervention: Eye pad for four hours (group 3)
Number of subjects: 133
Study 15678399 — intervention group
Group type: EXPERIMENTAL
Intervention: Eye pad until the next morning (group 4)
Number of subjects: 133
Study 11919129 — intervention group
Group type: EXPERIMENTAL
Intervention: Pioglitazone (PIO)
Number of subjects: 186
Study 11919129 — intervention group
Group type: COMPARATOR
Intervention: Rosiglitazone (ROSI)
Number of subjects: 186
Study 11919129 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (PIO and ROSI)
Number of subjects: 186
Study 10088734 — intervention group
Group type: EXPERIMENTAL
Intervention: Astigmatic keratotomy
Number of subjects: 95
Study 8747677 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypnotherapy (HT)
Number of subjects: 22
Study 8747677 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychophysiological therapy (PP)
Number of subjects: 22
Study 8747677 — intervention group
Group type: COMPARATOR
Intervention: Control group (patients treated under general anesthesia)
Number of subjects: 22
Study 2057400 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual teaching using self-modeling in addition to a breast model
Number of subjects: 79
Study 2057400 — intervention group
Group type: COMPARATOR
Intervention: Group teaching using only a breast model
Number of subjects: 79
Study 6405490 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-litre bag system
Number of subjects: 10
Study 6405490 — intervention group
Group type: COMPARATOR
Intervention: Conventional multiple-bottle system
Number of subjects: 10
Study 31489910 — intervention group
Group type: EXPERIMENTAL
Intervention: 9 meals daily (9M)
Number of subjects: 18
Study 31489910 — intervention group
Group type: COMPARATOR
Intervention: 3 meals daily (3M)
Number of subjects: 18
Study 30396619 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided imagery
Number of subjects: 80
Study 30396619 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 80
Study 26797700 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-intensity plyometric exercise
Number of subjects: 24
Study 26797700 — intervention group
Group type: COMPARATOR
Intervention: High-intensity plyometric exercise
Number of subjects: 24
Study 25156992 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin
Number of subjects: 1224
Study 25156992 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1224
Study 23213288 — intervention group
Group type: EXPERIMENTAL
Intervention: Real rTMS combined with speech and language therapy
Number of subjects: 26
Study 23213288 — intervention group
Group type: COMPARATOR
Intervention: Sham rTMS combined with speech and language therapy
Number of subjects: 26
Study 20022345 — intervention group
Group type: EXPERIMENTAL
Intervention: Venlafaxine
Number of subjects: 70
Study 20022345 — intervention group
Group type: EXPERIMENTAL
Intervention: Mirtazapine
Number of subjects: 70
Study 20022345 — intervention group
Group type: COMPARATOR
Intervention: Control (Healthy Controls)
Number of subjects: 70
Study 17923463 — intervention group
Group type: EXPERIMENTAL
Intervention: valsartan 320 mg
Number of subjects: 1188
Study 17923463 — intervention group
Group type: COMPARATOR
Intervention: valsartan/hydrochlorothiazide 320 mg/12.5 mg
Number of subjects: 1188
Study 15773961 — intervention group
Group type: EXPERIMENTAL
Intervention: Tacrolimus (TAC)
Number of subjects: 35
Study 15773961 — intervention group
Group type: COMPARATOR
Intervention: Cyclosporine (CSA)
Number of subjects: 35
Study 12127609 — intervention group
Group type: EXPERIMENTAL
Intervention: CK-MB measurements
Number of subjects: 222
Study 12127609 — intervention group
Group type: EXPERIMENTAL
Intervention: Troponin T measurements
Number of subjects: 222
Study 12127609 — intervention group
Group type: EXPERIMENTAL
Intervention: Troponin I measurements
Number of subjects: 222
Study 12127609 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall findings
Number of subjects: 222
Study 10418646 — intervention group
Group type: EXPERIMENTAL
Intervention: Desflurane with N2O
Number of subjects: 60
Study 10418646 — intervention group
Group type: COMPARATOR
Intervention: Desflurane without N2O (AIR-O2 mixture)
Number of subjects: 60
Study 7552926 — intervention group
Group type: EXPERIMENTAL
Intervention: Salmeterol 42 micrograms twice daily
Number of subjects: 556
Study 7552926 — intervention group
Group type: COMPARATOR
Intervention: Albuterol 180 micrograms four times daily
Number of subjects: 556
Study 7552926 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 556
Study 2199801 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin
Number of subjects: 60
Study 2199801 — intervention group
Group type: COMPARATOR
Intervention: Cholestyramine
Number of subjects: 60
Study 2199801 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined therapy (Simvastatin + Cholestyramine)
Number of subjects: 60
Study 374178 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxycycline, 100 mg daily for 3 weeks
Number of subjects: 50
Study 374178 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 31461355 — intervention group
Group type: EXPERIMENTAL
Intervention: Morning serum cortisol (MSC)
Number of subjects: 306
Study 31947163 — intervention group
Group type: EXPERIMENTAL
Intervention: Near Infrared (NIR) spectrometric monitoring of lactate levels using solution samples with varying concentrations of sodium lactate in isotonic Phosphate Buffer Solution (PBS) at pH 7.4.
Number of subjects: 0
Study 31947163 — intervention group
Group type: EXPERIMENTAL
Intervention: State-of-the-art spectrometer in the NIR region for lactate monitoring.
Number of subjects: 0
Study 28757533 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbonated water ingestion (CW)
Number of subjects: 13
Study 28757533 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbonated water sham-feeding (CW-SF)
Number of subjects: 13
Study 28757533 — intervention group
Group type: COMPARATOR
Intervention: Water ingestion (W)
Number of subjects: 13
Study 28757533 — intervention group
Group type: COMPARATOR
Intervention: Water sham-feeding (W-SF)
Number of subjects: 13
Study 26467096 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekly automated text messages (SMS-Track) reporting the number of days with bothersome LBP (0-7 days) over 1 year.
Number of subjects: 0
Study 23354667 — intervention group
Group type: EXPERIMENTAL
Intervention: Experienced observers
Number of subjects: 14
Study 23354667 — intervention group
Group type: EXPERIMENTAL
Intervention: Naïve observers
Number of subjects: 14
Study 23354667 — intervention group
Group type: COMPARATOR
Intervention: Real flash trials
Number of subjects: 14
Study 23354667 — intervention group
Group type: COMPARATOR
Intervention: Illusory flash trials
Number of subjects: 14
Study 22266771 — intervention group
Group type: EXPERIMENTAL
Intervention: Everolimus-eluting stents (EES)
Number of subjects: 863
Study 22266771 — intervention group
Group type: COMPARATOR
Intervention: Paclitaxel-eluting stents (PES)
Number of subjects: 863
Study 21156747 — intervention group
Group type: EXPERIMENTAL
Intervention: Black tea with cheese fondue
Number of subjects: 20
Study 21156747 — intervention group
Group type: EXPERIMENTAL
Intervention: Water with cheese fondue
Number of subjects: 20
Study 21156747 — intervention group
Group type: COMPARATOR
Intervention: White wine with cheese fondue
Number of subjects: 20
Study 21156747 — intervention group
Group type: COMPARATOR
Intervention: Schnapps with cheese fondue
Number of subjects: 20
Study 21156747 — intervention group
Group type: EXPERIMENTAL
Intervention: Both wine and schnapps
Number of subjects: 20
Study 21156747 — intervention group
Group type: COMPARATOR
Intervention: Wine
Number of subjects: 20
Study 21156747 — intervention group
Group type: EXPERIMENTAL
Intervention: Tea
Number of subjects: 20
Study 21156747 — intervention group
Group type: EXPERIMENTAL
Intervention: Dyspeptic symptoms
Number of subjects: 20
Study 17290332 — intervention group
Group type: EXPERIMENTAL
Intervention: Anticoagulation therapy
Number of subjects: 0
Study 17290332 — intervention group
Group type: EXPERIMENTAL
Intervention: Trauma
Number of subjects: 0
Study 17290332 — intervention group
Group type: EXPERIMENTAL
Intervention: Benign and malignant tumors of the adrenal gland
Number of subjects: 0
Study 12920568 — intervention group
Group type: EXPERIMENTAL
Intervention: Thallium-201 muscle perfusion scan (Tl-201 muscle scan)
Number of subjects: 25
Study 12920568 — intervention group
Group type: COMPARATOR
Intervention: Control group (healthy, age-matched women)
Number of subjects: 25
Study 11137102 — intervention group
Group type: EXPERIMENTAL
Intervention: Garlic preparation (500 mg dehydrated garlic powder/day)
Number of subjects: 51
Study 11137102 — intervention group
Group type: EXPERIMENTAL
Intervention: Garlic preparation (1000 mg dehydrated garlic powder/day)
Number of subjects: 51
Study 11137102 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 51
Study 9853084 — intervention group
Group type: EXPERIMENTAL
Intervention: Growth hormone (GH) treatment
Number of subjects: 12
Study 9853084 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment only
Number of subjects: 12
Study 8061852 — intervention group
Group type: EXPERIMENTAL
Intervention: Spirapril (3, 6, 12, or 24 mg once daily)
Number of subjects: 283
Study 8061852 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 283
Study 8061852 — intervention group
Group type: EXPERIMENTAL
Intervention: Spirapril (all doses)
Number of subjects: 283
Study 8061852 — intervention group
Group type: EXPERIMENTAL
Intervention: Spirapril
Number of subjects: 283
Study 8061852 — intervention group
Group type: COMPARATOR
Intervention: Spirapril and Placebo
Number of subjects: 283
Study 3243924 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 mg prazosin
Number of subjects: 24
Study 3243924 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 mg prazosin
Number of subjects: 24
Study 3243924 — intervention group
Group type: EXPERIMENTAL
Intervention: 12 mg prazosin
Number of subjects: 24
Study 3243924 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher dosage ranges (6 mg and 12 mg)
Number of subjects: 24
Study 3243924 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 24
Study 29698917 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 76
Study 29698917 — intervention group
Group type: COMPARATOR
Intervention: Support Therapy (ST)
Number of subjects: 76
Study 27022799 — intervention group
Group type: COMPARATOR
Intervention: Incentive Spirometry (IS)
Number of subjects: 0
Study 27022799 — intervention group
Group type: EXPERIMENTAL
Intervention: Breathing retraining exercises by a physiotherapist
Number of subjects: 0
Study 24041585 — intervention group
Group type: EXPERIMENTAL
Intervention: Walking with poles (2-point style)
Number of subjects: 35
Study 24041585 — intervention group
Group type: EXPERIMENTAL
Intervention: Walking with poles (3-point style)
Number of subjects: 35
Study 24041585 — intervention group
Group type: COMPARATOR
Intervention: No poles
Number of subjects: 35
Study 24418874 — intervention group
Group type: EXPERIMENTAL
Intervention: Dead-cells intake (n=15, viable cells were heat sterilized)
Number of subjects: 44
Study 24418874 — intervention group
Group type: EXPERIMENTAL
Intervention: Viable-cells intake (n=14, 3.0×10⁵ colony-forming units of viable LAB cells per sample)
Number of subjects: 44
Study 24418874 — intervention group
Group type: COMPARATOR
Intervention: Placebo intake (n=15, LAB removed from the pickles)
Number of subjects: 44
Study 20868259 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser Iridotomy (LI) in one eye
Number of subjects: 870
Study 20868259 — intervention group
Group type: COMPARATOR
Intervention: No treatment (Control)
Number of subjects: 870
Study 18809622 — intervention group
Group type: EXPERIMENTAL
Intervention: Multicomponent organizational intervention (TRANSLATE)
Number of subjects: 8405
Study 16161729 — intervention group
Group type: EXPERIMENTAL
Intervention: EEG biofeedback protocol
Number of subjects: 121
Study 16161729 — intervention group
Group type: COMPARATOR
Intervention: Control group (additional time in treatment)
Number of subjects: 121
Study 12892455 — intervention group
Group type: EXPERIMENTAL
Intervention: Early enteral nutrition (EN) in D(+) patients (n=13)
Number of subjects: 39
Study 12892455 — intervention group
Group type: EXPERIMENTAL
Intervention: Early enteral nutrition (EN) in D(-) patients (n=7)
Number of subjects: 39
Study 12892455 — intervention group
Group type: COMPARATOR
Intervention: Parenteral nutrition (PN) in D(+) patients (n=12)
Number of subjects: 39
Study 12892455 — intervention group
Group type: COMPARATOR
Intervention: Parenteral nutrition (PN) in D(-) patients (n=7)
Number of subjects: 39
Study 10230189 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertraline (average dose of 167 mg/day)
Number of subjects: 187
Study 10230189 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 187
Study 8558315 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium carbonate co‐ingested with 40 g of a cereal product containing 16 g wheat bran
Number of subjects: 0
Study 8558315 — intervention group
Group type: COMPARATOR
Intervention: Calcium carbonate ingested without bran
Number of subjects: 0
Study 1991366 — intervention group
Group type: EXPERIMENTAL
Intervention: Colestipol-niacin therapy plus diet
Number of subjects: 0
Study 6576807 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 mg vaginal prostaglandin E2 pessaries
Number of subjects: 36
Study 6576807 — intervention group
Group type: COMPARATOR
Intervention: intravenous oxytocin
Number of subjects: 36
Study 30478008 — intervention group
Group type: EXPERIMENTAL
Intervention: Valacyclovir (1.5 g BID)
Number of subjects: 170
Study 30478008 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 170
Study 29687335 — intervention group
Group type: EXPERIMENTAL
Intervention: PF ophthalmic solution containing HA 0.4% and TAU 0.5%, QID
Number of subjects: 39
Study 29687335 — intervention group
Group type: COMPARATOR
Intervention: PF ophthalmic solution containing HA 0.2%, QID
Number of subjects: 39
Study 29687335 — intervention group
Group type: COMPARATOR
Intervention: Comparison between groups
Number of subjects: 39
Study 26802153 — intervention group
Group type: EXPERIMENTAL
Intervention: nab-paclitaxel plus gemcitabine (nab-P + Gem)
Number of subjects: 257
Study 26802153 — intervention group
Group type: COMPARATOR
Intervention: gemcitabine alone (Gem)
Number of subjects: 257
Study 24205807 — intervention group
Group type: EXPERIMENTAL
Intervention: Electronic Diary (ED)
Number of subjects: 0
Study 24205807 — intervention group
Group type: EXPERIMENTAL
Intervention: Food Diary (FD)
Number of subjects: 0
Study 24205807 — intervention group
Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 0
Study 22278094 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin (OT) application
Number of subjects: 55
Study 22278094 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 55
Study 21146656 — intervention group
Group type: EXPERIMENTAL
Intervention: Thrombus aspiration followed by PCI
Number of subjects: 5000
Study 21146656 — intervention group
Group type: COMPARATOR
Intervention: Conventional PCI
Number of subjects: 5000
Study 17071141 — intervention group
Group type: EXPERIMENTAL
Intervention: Lamotrigine
Number of subjects: 70
Study 17071141 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study 17071141 — intervention group
Group type: EXPERIMENTAL
Intervention: Lamotrigine (subset with mild depression)
Number of subjects: 70
Study 17071141 — intervention group
Group type: COMPARATOR
Intervention: Placebo (subset with mild depression)
Number of subjects: 70
Study 15060773 — intervention group
Group type: EXPERIMENTAL
Intervention: Computed tomography (CT) assessment
Number of subjects: 35
Study 15060773 — intervention group
Group type: COMPARATOR
Intervention: Standard radiographs
Number of subjects: 35
Study 12536591 — intervention group
Group type: EXPERIMENTAL
Intervention: 131I alone
Number of subjects: 187
Study 12536591 — intervention group
Group type: EXPERIMENTAL
Intervention: 131I plus thyrostatic medication (PTU)
Number of subjects: 187
Study 9696456 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg morphine (p.o.)
Number of subjects: 18
Study 9696456 — intervention group
Group type: EXPERIMENTAL
Intervention: 170 mg codeine (p.o.)
Number of subjects: 18
Study 9696456 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 7656919 — intervention group
Group type: EXPERIMENTAL
Intervention: Physostigmine (12.5 micrograms kg‐1) infused intravenously over 10 min
Number of subjects: 26
Study 7656919 — intervention group
Group type: EXPERIMENTAL
Intervention: Apomorphine (60 micrograms kg‐1) injected subcutaneously
Number of subjects: 26
Study 7656919 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (control test)
Number of subjects: 26
Study 2526767 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotinamide 1 g/day
Number of subjects: 20
Study 2526767 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 987761 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant chemoimmunotherapy (cyclophosphamide, methotrexate, fluorouracil, and BCG vaccine +/− an irradiated allogeneic tumor cell vaccine)
Number of subjects: 57
Study 987761 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant chemoimmunotherapy
Number of subjects: 57
Study 31895295 — intervention group
Group type: EXPERIMENTAL
Intervention: Light-intensity physical activity (5 min every 30 min)
Number of subjects: 129
Study 31895295 — intervention group
Group type: COMPARATOR
Intervention: Standing
Number of subjects: 129
Study 29428266 — intervention group
Group type: EXPERIMENTAL
Intervention: Amniotic membrane allograft
Number of subjects: 16
Study 29428266 — intervention group
Group type: COMPARATOR
Intervention: Temporal muscle fascia autograft
Number of subjects: 16
Study 26865048 — intervention group
Group type: EXPERIMENTAL
Intervention: HZ/su (Shingrix) vaccine
Number of subjects: 0
Study 26865048 — intervention group
Group type: EXPERIMENTAL
Intervention: Local injection site pain and swelling
Number of subjects: 0